Outlook Therapeutics (OTLK) Debt Ratio (2015 - 2026)
Outlook Therapeutics' (OTLK) Debt Ratio was 0.96 for fiscal Q2 2026 (quarter ended Mar 31, 2026), down 44.7% from 1.73 a year earlier and down 52.3% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Debt Ratio (2015 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Debt Ratio at Outlook Therapeutics was 3.22, up 215.5% from FY2024.
- By fiscal year, Debt Ratio came in at 1.02 in FY2024 (-7.2%), 1.10 in FY2023 (+187.7%), 0.38 in FY2022 (-26.0%) and 0.52 in FY2021 (+123.3%).
- The fiscal Q2 2026 figure ranks as the lowest quarterly Debt Ratio since fiscal Q3 2024.
- Year over year, Debt Ratio gained in five of the last eight quarters, with growth averaging 52.8%.
- The high point for year-over-year Debt Ratio in five years was fiscal Q1 2024 (growth of 232.0%); the low point was fiscal Q1 2022 (a decline of 68.0%).
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at 2.01 (Q1 2026), 3.22 (Q4 2025) and 1.54 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Outlook Therapeutics | 86.15 Mn | 50.40 Mn | -8,265.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.96 |
| Dec 31, 2025 | 2.01 |
| Sep 30, 2025 | 3.22 |
| Jun 30, 2025 | 1.54 |
| Mar 31, 2025 | 1.73 |
| Dec 31, 2024 | 1.81 |
| Sep 30, 2024 | 1.02 |
| Jun 30, 2024 | 0.69 |
| Mar 31, 2024 | 0.76 |
| Dec 31, 2023 | 1.69 |
| Sep 30, 2023 | 1.10 |
| Jun 30, 2023 | 0.78 |
| Mar 31, 2023 | 0.59 |
| Dec 31, 2022 | 0.51 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.27 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.28 |
| Sep 30, 2021 | 0.52 |
| Jun 30, 2021 | 0.35 |
API Access
Outlook Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();